PCM
MDXH icon

Pentwater Capital Management’s MDxHealth MDXH Stock Holding History

Pentwater Capital Management’s Portfolio MDXH Stock Details MDXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-228,300
Closed -$740K – 141
2023
Q1 		$740K Buy
+228,300
New +$1.04M 0.01% 124

Other funds holding MDXH

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Pentwater Capital Management's MDXH Position: Q2 2023 in Review

Pentwater Capital Management sold out of MDxHealth (MDXH) in Q2 2023, closing a stake of 228,300 shares — an estimated $740K sold.

Pentwater Capital Management first reported a position in MDXH in Q1 2023 and held it in 1 quarter. The position peaked at $740K in Q1 2023. 19 funds tracked by Wall St. Rank hold MDXH as of Q2 2023.

  • Pentwater Capital Management reported no remaining MDxHealth position as of Q2 2023 after selling out during the quarter.
  • Pentwater Capital Management sold 228,300 MDxHealth shares in Q2 2023, an estimated $740K.
  • Pentwater Capital Management first reported a position in MDxHealth in Q1 2023 and held it in 1 quarter.
  • Pentwater Capital Management's MDxHealth position peaked at $740K in Q1 2023.
  • 19 funds tracked by Wall St. Rank held MDxHealth as of Q2 2023.

Based on Pentwater Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.